Our principal finding useful for a molecular classification was the very high expression of SPARC (70% incidence, as bone metastasis) in dysplastic epithelium, associated with ductal breast carcinoma, and in bone metastatic cells and stroma (ECM and supportive cells). The gene discussed is SPARC; the disease is bone metastasis.